Inactive Instrument

News New York Global Innovations Inc Other OTC

Equities

US45727E1064

End-of-day quote Other OTC Other stock markets
- ^USD	-

2023	Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Manuka Announces Review of Strategic Alternatives	17/11	GL
Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Manuka, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19	CI
ARTEMIS THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	04/23/04	AQ
ARTEMIS THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	07/23/07	AQ
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	01/23/01	AQ
Artemis Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt	31/23/31	CI
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/22/15	AQ
Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
ARTEMIS THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	10/22/10	AQ
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23/22/23	AQ
Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	23/22/23	CI
ARTEMIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	02/22/02	AQ
ARTEMIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	27/22/27	AQ
Artemis Therapeutics Inc. Announces Executive Changes	27/22/27	CI
Artemis Therapeutics : Opinion on the Financial Statements - Form 8-K	06/22/06	PU
ARTEMIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Change in Shell Company Status, Financial Statements and Exhibits (form 8-K)	06/22/06	AQ
Manuka Ltd completed the acquisition of Artemis Therapeutics Inc. in a reverse merger transaction.	30/22/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News New York Global Innovations Inc Other OTC

Equities

US45727E1064

Summary

Filters